AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
AstraZeneca's Strategic Momentum in Pharma Innovation
February 13, 2025 03:32 PM AEDT| By Team Kalkine MediaAstraZeneca's Strategic Momentum in Pharma Innovation
GSK PLC's Specialty Medicines Powering Global Healthcare Innovation
February 13, 2025 03:31 PM AEDT| By Team Kalkine MediaGSK PLC's Specialty Medicines Powering Global Healthcare Innovation
How Is Beximco Pharmaceuticals Performing In The Market?
February 13, 2025 10:53 AM AEDT| By Team Kalkine MediaHighlights:,Beximco Pharmaceuticals' stock moved above its fifty-day average,,indicating,recent market activity.,The company has a long-standing presence in the pharmaceutical sector, manufacturing and exporting medicines globally.,Market activity re...
Is GSK Facing Setbacks Amidst Recent Earnings Performance?
February 12, 2025 08:15 PM AEDT| By Team Kalkine MediaHighlights:,GSK's stock opened lower with fluctuating price trends.,The company reports a notable net margin and return on equity.,A 52-week low and high reveal a wider price range.,GSK (LSE:GSK) operates in the healthcare sector, focusing on pharmac...
EKF Diagnostics Faces Decline As Stock Drops Below Key Average
February 12, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,EKF Diagnostics shares recently dropped below their 200-day moving average.,The company focuses on diagnostics, specializing in Hematology and Diabetes.,EKF operates five manufacturing sites in the US and Germany, serving over 120 countri...
Could Institutional Investors Influence GSK plc (LON:GSK) After a Notable Shift?
February 10, 2025 10:15 PM AEDT| By Team Kalkine MediaHighlights,Institutional ownership of GSK plc,(LON:GSK),stands at 86%, making it highly sensitive to their trading decisions.,A small group of 23 institutional investors collectively control over half of the company's shares.,Recent valuation changes...
Oncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financial and Operational Shifts
February 10, 2025 08:32 PM AEDT| By Team Kalkine MediaOncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financial and Operational Shifts
Could Artemis Uncover Hidden Gold Reserves in the Pilbara?
February 10, 2025 07:30 PM AEDT| By Team Kalkine MediaCould Artemis Uncover Hidden Gold Reserves in the Pilbara?
Cardiogeni (AQSE: CGNI) Signs Memorandum of Understanding with UAE Private Office of Sheikh Al Qassimi
February 10, 2025 06:18 PM AEDT| By Team Kalkine MediaHighlights,Cardiogeni secures £20 million funding for heart failure clinical trials in UAE.,Joint venture with UAE Private Office to develop medicines for GCC region.,Initial investment of £5 million planned for H1 2025 to accelerate trials.,Cardioge...
Could Faron's New Fundraising Boost Breakthroughs in Cancer Therapy?
February 10, 2025 04:30 PM AEDT| By Team Kalkine MediaCould Faron's New Fundraising Boost Breakthroughs in Cancer Therapy?
Biotechnology Sector: Oncimmune's Strategic Growth and Industry Leadership
February 09, 2025 03:30 AM AEDT| By Team Kalkine MediaIn Case You Missed It: Insights from Oncimmune's CEO on Projected 2025 Growth and Upcoming Deals
Could This Breakthrough in DNA Analysis Transform Liquid Biopsies?
February 08, 2025 11:30 PM AEDT| By Team Kalkine MediaCould This Breakthrough in DNA Analysis Transform Liquid Biopsies?
Faron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Progress in Cancer Immunotherapy
February 06, 2025 11:29 PM AEDT| By Team Kalkine MediaFaron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Progress in Cancer Immunotherapy
AstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic Growth in Pharma
February 06, 2025 11:28 PM AEDT| By Team Kalkine MediaAstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic Growth in Pharma
AstraZeneca Reports 21% Revenue Growth in FY24, Driven by 19% Rise in Product Sales
February 06, 2025 06:51 PM AEDT| By Team Kalkine MediaHighlights,Revenue Surge:,AstraZeneca’s total revenue rose by,21%,to,$54.1 billion,, led by,19% growth in product sales,and continued momentum in partnered medicines.,Earnings & Dividend Boost:,Core earnings per share (EPS) climbed,19%,to,$8.21,, wit...
STERIS (NYSE:STE) Sees 42% Growth Over Five Years Despite Recent Decline
February 05, 2025 08:16 PM AEDT| By Team Kalkine MediaHighlights,Share Price Rises Over Five Years,STERIS (STE) recorded a 42% increase over the past five years, reflecting steady growth.,Recent Performance Declines,The stock declined by 2.9% in the last year despite long-term gains.,Earnings Growth Out...
Oxford BioDynamics (AIM: OBD) Announces Breakthrough Colorectal Cancer Detection Technology with High Accuracy in Multi-Centre Study
February 05, 2025 06:31 PM AEDT| By Team Kalkine MediaHighlights,EpiSwitch® 3D genomics platform demonstrates 81% accuracy for early-stage CRC detection.,Non-cancerous polyps identified with 82% accuracy using blood-based test.,Collaboration with leading institutions shows promising diagnostic potential...
_02_04_2025_16_36_34_782763.jpg)
Bioventix (LON:BVXP) Stock Drops Below Two-Hundred-Day Moving Average
February 04, 2025 08:34 PM AEDT| By Team Kalkine MediaBioventix (BVXP) saw its stock price dip below the two-hundred-day moving average.,The stock traded as low as GBX 3,051, signaling a shift in its price trend.,The company’s shares experienced a low trading volume of 3,715 shares.,Bioventix PLC (LON:B...
RUA Life Sciences Delivers Positive Performance from ABISS French Subsidiary Following Acquisition
February 03, 2025 06:22 PM AEDT| By Team Kalkine MediaHighlights:,Revenue Growth:,ABISS achieved €2.3 million in revenue for the year to December 2024, marking a 7% increase over 2023.,Profit Turnaround:,The subsidiary recorded a profit before tax of €46k, a significant recovery from the previous year’s...
Alliance Pharma Reports Stable Revenues in 2024 Trading Update
January 31, 2025 06:51 PM AEDT| By Team Kalkine MediaHighlights,Total revenues for 2024 reached £180.3 million, marking a 1% YoY decline but a 1% increase at constant exchange rates (CER).,Consumer healthcare revenue dropped by 2% CER, while prescription medicine revenue saw an 8% CER rise.,The company...
AI on the Rise: A Look at Top AI Companies and Their Stocks